Clinical Trial Update: EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for MTX-474 in participants with diffuse cutaneous systemic sclerosis (dcSSc) shows the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis

Drugs mentioned

• MTX-474

Snippet

Sponsor: Mediar Therapeutics | Conditions: Diffuse Cutaneous Systemic Sclerosis | Phase 2 | Status: RECRUITING